Drug Database
Back to search

Poland· PL-100341420

Hypnomidate

A etomidate product containing etomidatum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC N01AX07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedHypnomidateATCN01AX07REGISTER NO.PL-100341420PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about etomidatumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Etomidate is registered in 12 of 19 countries.

Countries holding a registration under ATC N01AX07 (etomidate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search etomidate products by name

Etomidate · ATC N01AX07

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Etomidatum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
N01AX07
ATC class
Etomidate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991216931

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

59 interactions on record for etomidate.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check etomidate against other medicinesHow interaction checks work

Etomidate · interactions on record

59 records

  • 4 moderate
  • 55 info

Most severe, free to view

  • EthanolB05XX04moderate
  • EthanolV03AB16moderate
  • EthanolV03AZ01moderate
  • EthanolV07AB03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etomidate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etomidate products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Etomidat-Lipuro B. Braun Melsungen, Hypnomidate
  • Belgium · Etomidate-Lipuro B. Braun Melsungen, Hypnomidate
  • Czechia · Hypnomidate
  • Germany · Etomidat-Lipuro B. Braun Melsungen, Hypnomidate
  • Spain · Etomidato-Lipuro B.Braun Melsungen, Hypnomidate
  • France · Etomidate Lipuro B. Braun Melsungen, Hypnomidate
  • United Kingdom (Northern Ireland) · Etomidate-Lipuro B. Braun Melsungen, Hypnomidate
  • Croatia · Hypnomidate
  • Hungary · Etomidat-Lipuro B. Braun Melsungen
  • Lithuania · Etomidate Braun
  • Luxembourg · Etomidat-Lipuro B. Braun Melsungen, Hypnomidate
  • Netherlands · Etomidaat Lipuro B.Braun Melsungen, Hypnomidate
  • Portugal · Etomidato-Lipuro B. Braun Medical
  • Romania · Etomidat - Lipuro B. Braun Melsungen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/56dc1e04-1c4d-4200-8821-d1cd8c0de306
GET /v1/drugs/56dc1e04-1c4d-4200-8821-d1cd8c0de306?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "2 mg/ml",
  "packaging": "05909991216931 ¦ Lz ¦ 107856\n5 amp. 10 ml",
  "substance": "Etomidatum 2 mg/ml",
  "common_name": "Etomidatum",
  "pl_product_id": "100341420",
  "pozwolenie_nr": "163/15",
  "auth_procedure": "IR",
  "authorisation_validity": "2025-04-08"
}
API referenceMCP serverPlans

See everything about etomidate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console